Atovaquone Oral Suspension USP, 750 mg/5 mL, Packaged in 210 mL bottle, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured by: Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India, NDC# 31722-629-21.
Published May 17, 2023 · Recall initiated: March 13, 2023
Summary
FDA records drug Class I recall D-0567-2023, published May 17, 2023 and initiated March 13, 2023. Recalling firm: Camber Pharmaceuticals Inc.; Status: Ongoing; Reported quantity: 1568 bottles; Lot: Lot# E220182, Exp. 12/31/2023. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Microbial Contamination of Non-Sterile Product: Objectionable organism, identified as Bacillus cereus, found in product during testing of repackaged product.
What to do
Voluntary: Firm initiated · Letter
Get an email if ATOVAQUONE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ATOVAQUONE
- Manufacturer
- Camber Pharmaceuticals Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0331722629218
- Lot
- Lot# E220182, Exp. 12/31/2023
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAtovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc.,October 23, 2024
- FDACalcitonin Salmon (synthetic origin) Nasal Spray, 2200 USP Calcitonin Salmon Units/mL, 200 USP CalcitoninMay 17, 2023
- FDAGabapentin Tablets, USP 600 mg, packaged in Cartons of 100 tablets (10 tablets per blister pack x 10), RxMay 17, 2023
- FDAVITROS 5600 Integrated System- For use in the in vitro quantitative, semi-quantitative, and qualitativeMay 10, 2023
- FDALINK SLED Knee System POREX ENDO MODEL SLED TIBIAL COMP 8 MM X 55 MM Item Number: 15-2230/15May 10, 2023
- FDALINK SLED Knee System POREX ENDO SLED KNEE FEM COMP, MEDIUM Item Number: 15-2220/52May 10, 2023
Questions about this recall
Was Atovaquone Oral Suspension USP, 750 mg/5 mL, Packaged in 210 mL bottle, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured by: Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India, NDC# 31722-629-21. recalled?
Yes. FDA published recall D-0567-2023 on May 17, 2023. Reported hazard: Microbial Contamination of Non-Sterile Product: Objectionable organism, identified as Bacillus cereus, found in product during testing of repackaged product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ATOVAQUONE. UPC: 0331722629218.